(资料图)

CFi.CN讯：科美诊断（股票代码：688468）公布科美诊断技术股份有限公司2025年年度报告摘要。

2025年2024年本年比上年增减(%)2023年总资产1,760,943,332.191,832,158,296.89-3.891,820,562,566.47归属于上市公司股东的净资产1,410,895,512.631,416,307,137.37-0.381,388,801,768.59营业收入332,678,626.15436,289,767.28-23.75445,340,815.75利润总额49,818,577.77137,918,825.97-63.88166,119,706.14归属于上市公司股东的净利润43,912,518.56127,074,717.39-65.44147,373,517.73归属于上市公司股东的扣除非经常性损益的净利润26,572,639.79100,730,232.14-73.62121,317,262.48经营活动产生的现金流量净额93,895,166.85167,950,046.11-44.09173,053,196.46加权平均净资产收益率（%）3.129.18减少6.06个百分点10.73基本每股收益（元／股）0.110.32-65.630.37稀释每股收益（元／股）0.110.32-65.630.37研发投入占营业收入的比例（%）22.0417.71增加4.33个百分点18.78